Literature DB >> 18274736

Determination of IGF-I in horse plasma by LC electrospray ionisation mass spectrometry.

Marie-Agnes Popot1, Adrian R Woolfitt, Patrice Garcia, Jean-Claude Tabet.   

Abstract

The insulin-like-growth factor (IGF-I) peptide is considered to be the main indirect marker for growth hormone administration (GH) in a horse. Further to a previous investigation on measurement of IGF-I in plasma samples by mass spectrometry, this study focuses on quantitative and qualitative analysis of intact IGF-I in horse plasma. First, protein-transposing software has been developed for IGF-I to facilitate its quantification by HPLC-electrospray-ion-trap mass spectrometry. Second, product-ion scan experiments on IGF-I have been conducted on standard samples, non-fortified equine plasma samples, fortified plasma samples, and equine GH post-administration samples. This "top-down" approach method enables characterisation of fragment ions corresponding to the carboxy terminal end, which can be useful for the confirmation of the presence of IGF-I in plasma samples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274736     DOI: 10.1007/s00216-008-1889-z

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  3 in total

1.  Serum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this Technology.

Authors:  Richard Kin Ting Kam; Chung Shun Ho; Michael Ho Ming Chan
Journal:  EJIFCC       Date:  2016-12-01

2.  Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse.

Authors:  Courtnay L Baskerville; Nicholas J Bamford; Patricia A Harris; Simon R Bailey
Journal:  Open Vet J       Date:  2017-03-31

Review 3.  Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.

Authors:  David A Cowan; Danielle A Moncrieffe
Journal:  Drug Test Anal       Date:  2021-09-06       Impact factor: 3.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.